STAT

STAT+: Alnylam defends heart disease drugs after failure of AstraZeneca’s Wainua

STAT+: Alnylam defends heart disease drugs after failure of AstraZeneca’s WainuaWorldPing

An AstraZeneca heart disease trial failure has put Alnylam under pressure. It's mounting a defense of its medicines.

This is a short WorldPing brief. The full report was published by STAT.

Read the full report at STAT

Related news

ScienceDaily

Common supplements rival antibiotics for severe gum disease

Omega-3 and low-dose aspirin matched the effectiveness of antibiotics in a year-long study of patients with severe gum disease, with both approaches helping about 58% reach the treatment goal.

Brief by WorldPing · Original reporting by ScienceDaily

Pakistan to meet King Charles after Lord's controversyWorldPing
BBC Sport

Pakistan to meet King Charles after Lord's controversy

Pakistan will have an audience with King Charles this week, days after a threat to cancel their tour of England was made because of an interview with the sons of Imran Khan.

Brief by WorldPing · Original reporting by BBC Sport